Works matching IS 20445385 AND DT 2021 AND VI 11 AND IP 2

Results: 11

Mass spectrometry for the evaluation of monoclonal proteins in multiple myeloma and related disorders: an International Myeloma Working Group Mass Spectrometry Committee Report.

Published in:

Blood Cancer Journal, 2021, v. 11, n. 2, p. 1, doi. 10.1038/s41408-021-00408-4

By:

Murray, David L.;
Puig, Noemi;
Kristinsson, Sigurdur;
Usmani, Saad Z.;
Dispenzieri, Angela;
Bianchi, Giada;
Kumar, Shaji;
Chng, Wee Joo;
Hajek, Roman;
Paiva, Bruno;
Waage, Anders;
Rajkumar, S. Vincent;
Durie, Brian

Publication type:

Article

Economic burden of disease progression among multiple myeloma patients who have received transplant and at least one line of therapy in the US.

Published in:

Blood Cancer Journal, 2021, v. 11, n. 2, p. 1, doi. 10.1038/s41408-021-00431-5

By:

Fonseca, Rafael;
Hagiwara, May;
Panjabi, Sumeet;
Yucel, Emre;
Buchanan, Jacqueline;
Delea, Thomas

Publication type:

Article

Polymorphisms in CXCR3 ligands predict early CXCL9 recovery and severe chronic GVHD.

Published in:

Blood Cancer Journal, 2021, v. 11, n. 2, p. 1, doi. 10.1038/s41408-021-00434-2

By:

Dai, Hao;
Rachakonda, Sivaramakrishna P.;
Penack, Olaf;
Blau, Igor W.;
Blau, Olga;
Radujkovic, Aleksandar;
Müller-Tidow, Carsten;
Dreger, Peter;
Kumar, Rajiv;
Luft, Thomas

Publication type:

Article

Acute myeloid leukemia: current progress and future directions.

Published in:

Blood Cancer Journal, 2021, v. 11, n. 2, p. 1, doi. 10.1038/s41408-021-00425-3

By:

Kantarjian, Hagop;
Kadia, Tapan;
DiNardo, Courtney;
Daver, Naval;
Borthakur, Gautam;
Jabbour, Elias;
Garcia-Manero, Guillermo;
Konopleva, Marina;
Ravandi, Farhad

Publication type:

Article

Management of patients with multiple myeloma beyond the clinical-trial setting: understanding the balance between efficacy, safety and tolerability, and quality of life.

Published in:

Blood Cancer Journal, 2021, v. 11, n. 2, p. 1, doi. 10.1038/s41408-021-00432-4

By:

Terpos, Evangelos;
Mikhael, Joseph;
Hajek, Roman;
Chari, Ajai;
Zweegman, Sonja;
Lee, Hans C.;
Mateos, María-Victoria;
Larocca, Alessandra;
Ramasamy, Karthik;
Kaiser, Martin;
Cook, Gordon;
Weisel, Katja C.;
Costello, Caitlin L.;
Elliott, Jennifer;
Palumbo, Antonio;
Usmani, Saad Z.

Publication type:

Article

Epcoritamab induces potent anti-tumor activity against malignant B-cells from patients with DLBCL, FL and MCL, irrespective of prior CD20 monoclonal antibody treatment.

Published in:

Blood Cancer Journal, 2021, v. 11, n. 2, p. 1, doi. 10.1038/s41408-021-00430-6

By:

van der Horst, Hilma J.;
de Jonge, A. Vera;
Hiemstra, Ida H.;
Gelderloos, Anne T.;
Berry, Daniella R. A. I.;
Hijmering, Nathalie J.;
van Essen, Hendrik F.;
de Jong, Daphne;
Chamuleau, Martine E. D.;
Zweegman, Sonja;
Breij, Esther C. W.;
Roemer, Margaretha G. M.;
Mutis, Tuna

Publication type:

Article

Ibrutinib and venetoclax target distinct subpopulations of CLL cells: implication for residual disease eradication.

Published in:

Blood Cancer Journal, 2021, v. 11, n. 2, p. 1, doi. 10.1038/s41408-021-00429-z

By:

Lu, Pin;
Wang, Shengchun;
Franzen, Carrie A.;
Venkataraman, Girish;
McClure, Rebecca;
Li, Lei;
Wu, Wenjun;
Niu, Nifang;
Sukhanova, Madina;
Pei, Jianming;
Baldwin, Donald A.;
Nejati, Reza;
Wasik, Mariusz A.;
Khan, Nadia;
Tu, Yifan;
Gao, Juehua;
Chen, Yihua;
Ma, Shuo;
Larson, Richard A.;
Wang, Y. Lynn

Publication type:

Article

Upregulation of AXL and β-catenin in chronic lymphocytic leukemia cells cultured with bone marrow stroma cells is associated with enhanced drug resistance.

Published in:

2021

By:

Sinha, Sutapa;
Secreto, Charla R.;
Boysen, Justin C.;
Lesnick, Connie;
Wang, Zhiquan;
Ding, Wei;
Call, Timothy G.;
Kenderian, Saad J.;
Parikh, Sameer A.;
Warner, Steven L.;
Bearss, David J.;
Ghosh, Asish K.;
Kay, Neil E.

Publication type:

Letter

Author Correction: Clonal hematopoiesis in patients with rheumatoid arthritis.

Published in:

2021

By:

Savola, Paula;
Lundgren, Sofie;
Keränen, Mikko A. I.;
Almusa, Henrikki;
Ellonen, Pekka;
Leirisalo-Repo, Marjatta;
Kelkka, Tiina;
Mustjoki, Satu

Publication type:

Correction Notice

Minimal residual disease negativity by next-generation flow cytometry is associated with improved organ response in AL amyloidosis.

Published in:

Blood Cancer Journal, 2021, v. 11, n. 2, p. 1, doi. 10.1038/s41408-021-00428-0

By:

Palladini, Giovanni;
Paiva, Bruno;
Wechalekar, Ashutosh;
Massa, Margherita;
Milani, Paolo;
Lasa, Marta;
Ravichandran, Sriram;
Krsnik, Isabel;
Basset, Marco;
Burgos, Leire;
Nuvolone, Mario;
Lecumberri, Ramón;
Foli, Andrea;
Puig, Noemi;
Sesta, Melania Antonietta;
Bozzola, Margherita;
Cascino, Pasquale;
Nevone, Alice;
Ripepi, Jessica;
Berti, Pierpaolo

Publication type:

Article

Characterization of rare germline variants in familial multiple myeloma.

Published in:

2021

By:

Catalano, Calogerina;
Paramasivam, Nagarajan;
Blocka, Joanna;
Giangiobbe, Sara;
Huhn, Stefanie;
Schlesner, Matthias;
Weinhold, Niels;
Sijmons, Rolf;
de Jong, Mirjam;
Langer, Christian;
Preuss, Klaus-Dieter;
Nilsson, Björn;
Durie, Brian;
Goldschmidt, Hartmut;
Bandapalli, Obul Reddy;
Hemminki, Kari;
Försti, Asta

Publication type:

Correction Notice